The global Interventional Oncology Market size was estimated at USD 2,930 million in 2024 and is projected to reach USD 5,601.6 million in 2031 at a CAGR of 9.7 % during the forecast period 2025-2031.
The interventional oncology market involves medical procedures that use minimally invasive techniques to treat cancer through targeted therapies. This field includes treatments such as tumor ablation, embolization, and percutaneous biopsy, typically guided by imaging technologies like CT scans, MRI, or ultrasound.
Get Free Sample Report: https://www.delvens.com/get-free-sample/interventional-oncology-market
Experts in the Interventional Oncology Market highlight several key trends driving growth and innovation. The interventional oncology market focuses on minimally invasive procedures used to treat cancer, such as tumor ablation, embolization, and biopsy, often guided by advanced imaging technologies. It caters to various cancer types, providing both curative and palliative treatment options, especially for patients who are not candidates for traditional surgery.
The market is driven by the rising global incidence of cancer, advancements in imaging and medical devices, and a shift towards less invasive, personalized treatments. Key trends include the adoption of image-guided techniques, innovations in embolization, and combination therapies, while drivers such as an aging population, increased awareness, and the demand for cost-effective care continue to fuel market growth.
North America to Dominate the Interventional Oncology Market
- North America holds a commanding position in the global market, capturing a share of around 35%, driven by factors such as the presence of leading market players, substantial healthcare spending, widespread awareness of minimally invasive techniques, a supportive regulatory environment, and a high incidence of cancer.
- The U.S. market is poised for notable growth, supported by the presence of key industry players, a favorable regulatory framework, intensified research and development efforts, and heightened government campaigns to raise cancer awareness.
Top Key Competitors:
- Medtronic plc
- Boston Scientific Corporation
- Johnson & Johnson (Ethicon)
- Baxter International Inc.
- Cook Medical
- R. Bard Inc. (Acquired by BD)
- AngioDynamics Inc.
- Stryker Corporation
- Braun Melsungen AG
- Terumo Corporation
- Siemens Healthineers
- GE Healthcare and More
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/interventional-oncology-market
Recent Developments
In August 2022, Boston Scientific Corporation acquired Obsidio, Inc., enhancing its interventional oncology and embolization portfolio by incorporating Gel Embolic Material (GEM) technology. This addition provides a unique solution for both patients and physicians.
In July 2021, Terumo Europe entered into a Memorandum of Understanding (MoU) with the University Medical Center Utrecht (UMC Utrecht) to expand their collaboration, aiming to advance education and innovation in the development of effective interventional oncology solutions.
In July 2020, Terumo Corporation acquired Quirem Medical, a healthcare startup based in the Netherlands, to strengthen its interventional oncology capabilities. The acquisition brings three integrated products—QuiremScout, QuiremSpheres, and Q-Suite—into the company’s portfolio, enabling physicians to deliver personalized treatments to patients.
Interventional Oncology Market Segmentations:
Based on Technique
- Ablation Therapies
- Embolization Therapies
- Biopsy Techniques
- Targeted Therapy Delivery Systems
- Image-Guided Procedures
Based on Procedure
- Tumor Ablation
- Tumor Biopsy
- Vascular Interventions
- Palliative Care
Based on Application
- Liver Cancer
- Lung Cancer
- Kidney Cancer
- Prostate Cancer
- Breast Cancer
- Other Cancer
Based on End Use
- Hospitals
- Specialty Clinics
- Others
The Report helps to identify the opportunities in Global Regions:
- North America (the United States, Canada, and Mexico)
- Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
- Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
- South America (Brazil etc.)
- The Middle East and Africa (North Africa and GCC Countries)
Access Full Report: https://www.delvens.com/report/interventional-oncology-market
In addition to the market data for the Interventional Oncology Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirements.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
Unit No. 01, 3rd Floor, Plot No. 56, Block B
Sector 2 Noida, Near Noida Sector 15 Metro Station 201301, IN
+44 20 3290 6466
+0120- 4903958
